NCT03275857View on ClinicalTrials.gov

Cisplatin in Castration Resistant Prostate Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 21, 2018

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Prostate Cancer
Interventions
DRUG

Cisplatin

Weekly IV

Trial Locations (1)

14642

Wilmot Cancer Institute, Rochester

All Listed Sponsors
collaborator

Roswell Park Cancer Institute

OTHER

lead

University of Rochester

OTHER

NCT03275857 - Cisplatin in Castration Resistant Prostate Cancer | Biotech Hunter | Biotech Hunter